D

제이에스링크

127120KOSDAQ

39.0 / 100

Reference Date: 2026-10-23

Financial Score12.5 / 40
News Sentiment12.5 / 25
Momentum4.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Plunged 46.1% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

JS Link operates in genomics analysis, personalized medicine, and diagnostics, leveraging advancements in genomic technology and rising demand for customized treatments. As genome sequencing costs have drastically decreased and bioinformatics becomes crucial for handling large data, the molecular diagnostics market is rapidly expanding. Establishing Asia-specific genomic databases is key to securing global competitiveness.

Number of Employees

139people

Average Salary

53.5M KRW

Score Calculation Basis

Detailed Financial Score

PER
—Industry Average 15.004.0Point
PBR
9.15Industry Average 1.200.0Point

7.6x industry avg (risky)

ROE
-35.13Industry Average 8.000.0Point

Well below industry avg

Debt Ratio
9.28Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20250.5 / 10 points
Revenue Growth Rate
0.5 / 3

Avg ▼3.0% (2-year basis)

Operating Profit Growth Rate
0.0 / 3

Avg ▼73.4% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -32.6% (declining, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position1.0Point

Near 52w low (2%, downtrend)

Current 16,780Won52-week high 48,90052-week low 16,050
1-month return0.0Point

1m -46.13% (strong drop)

Volume trend3.0Point

Volume flat

Detailed Disclosure

5 totalPositive 0Neutral 5Negative 0
  • Neutral주식등의대량보유상황보고서(일반)2026-10-16
  • Neutral주식등의대량보유상황보고서(일반)2026-10-12
  • Neutral주식등의대량보유상황보고서(일반)2026-10-08
  • Neutral유형자산취득결정(종속회사의주요경영사항)2026-10-01
  • Neutral기업설명회(IR)개최2026-09-30